[Federal Register Volume 83, Number 248 (Friday, December 28, 2018)]
[Notices]
[Pages 67458-67459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28313]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 04/04-0330]


Ballast Point Ventures III, L.P.; Notice Seeking Exemption Under 
Section 312 of the Small Business Investment Act, Conflicts of Interest

    Notice is hereby given that Ballast Point Ventures III, L.P., 401 
East Jackson Street, Suite 2300, Tampa, FL 33602, a Federal Licensee 
under the Small Business Investment Act of 1958, as amended (``the 
Act''), in connection with the financing in a small concern, has sought 
an exemption under Section 312 of the Act, Section 107.730, Financings 
which constitute Conflicts of Interest of the Small Business 
Administration (``SBA'') Rules and Regulations (13 CFR 107.730). 
Ballast Point Ventures III, L.P. proposes to invest $5 million in 
YPrime Inc., 263 Great Valley Parkway, Malvern, PA 19355.
    The financing is brought within the purview of Sec.  107.730(a)(1) 
and Sec.  107.730(a)(4) of the Regulations because Ballast Point 
Ventures II, LP and Ballast Point Ventures EF II, LP (together ``BPV 
II'') and YPrime expect to receive $30 million and $5 million, 
respectively, from the proposed $52.5 million transaction, including 
$47.5 million from the lead investor and $5 million from the Licensee. 
BPV II and YPrime Inc. are Associates to the Licensee. Thus, this 
transaction constitutes a Conflict of Interest requiring SBA's prior 
written exemption.
    Notice is hereby given that any interested person may submit 
written comments on this transaction within

[[Page 67459]]

fifteen days of the date of this publication to the Associate 
Administrator, Office of Investment and Innovation, U.S. Small Business 
Administration, 409 Third Street SW, Washington, DC 20416.

A. Joseph Shepard,
Associate Administrator for Office of Investment and Innovation.
[FR Doc. 2018-28313 Filed 12-27-18; 8:45 am]
 BILLING CODE 8025-01-P